Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer

Trial Details

NCT ID

NCT06850623

Phase

PHASE2

Sponsor

EXACT Therapeutics AS

Status

RECRUITING

Cancer Type

Pancreatic Ductal Adenocarcinoma Pancreatic Cancer

Interventions

• Acoustic Cluster Therapy
• Modified FOLFIRINOX

Locations (sample)

• Scottsdale, Arizona, United States|33.50921,-111.89903
• Stanford, California, United States|37.42411,-122.16608
• Boston, Massachusetts, United States|42.35843,-71.05977
• Detroit, Michigan, United States|42.33143,-83.04575
• Philadelphia, Pennsylvania, United States|39.95238,-75.16362

Key Eligibility Criteria

• Not deemed suitable for primary curative surgery and have radiographic and pathological disease consistent with inoperable LAPC or borderline resec…
• Suitable to receive treatment with mFOLFIRINOX according to the Investigator's assessment.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.